Influenza Diagnostics Market By Test Type Analysis (Traditional Diagnostic Tests, Viral Culture, Rapid Influenza Detection Tests (RIDT), Direct Fluorescent Antibody (DFA) Tests, Serological Assays, Molecular Diagnostic Tests, RT-PCR, Nucleic Acid Sequence-based Amplification (NASBA) Tests, Loop-mediated Isothermal Amplification-based Assays (LAMP), Simple Amplification-based Assays (SAMBA)); By End User Analysis (Hospitals & Clinics, Reference Laboratories) and By Regional Analysis – Global Forecast by 2023-2028
The Influenza Diagnostics Market is expected to be around US$ 1250 Million by 2028 at a CAGR of 8.5% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
8
REPORT DESCRIPTION
Influenza is an infectious disease caused by the infection virus. The most punctual existing depictions of flu were composed almost 2,500 years back by the antiquated Greek doctor Hippocrates. Generally, flu was attributed to various diverse specialists, including "terrible air" and a few distinct microbes.Influenza is a viral disease that attacks the respiratory system that influences nose, throat, and lungs and can cause minor or severe disease. Patients affected with influenza struggles with cough, sore throat, runny nose, headache, body aches, rhinitis, chill and fatigue.Influenza tends to spread fast amid the seasonal epidemics because the virus is transferred simply from one person to another via droplets and small particles produced while coughing and sneezing of the infected person. Rapid influenza diagnostic test is quick symptomatic trial of the quick antigen test sort that distinguishes the flu viral nucleoprotein antigen.
How Big is the Global Influenza Diagnostics Market?
The Influenza Diagnostics Market is expected to be around US$ 1250 Million by 2028 at a CAGR of 8.5% in the given forecast period.
The major driving factors of Influenza Diagnostics Market are as follows:
The restraining factors of Influenza Diagnostics Market are as follows:
The Influenza Diagnostics Market is segmented on the lines of its test type, end user and regional. Based on test type segmentation it covers traditional diagnostic tests, viral culture, rapid influenza detection tests (RIDT), direct fluorescent antibody (DFA) tests, serological assays, molecular diagnostic tests, RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAMP), simple amplification-based assays (SAMBA), other tests (Microarray-based Approaches and Nucleic Acid Sequencing Approaches). Based on end user segmentation it covers Hospitals & Clinics, Reference Laboratories, Other End Users. The Influenza Diagnostics Marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Influenza Diagnostics Market and related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for Influenza Diagnostics Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Influenza Diagnostics Marke twith the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Luminex Corporation (U.S.), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), DiaSorin (Italy), SA Scientific (U.S.), and Quidel Corporation (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Influenza Diagnostics Market has been segmented as below:
By Test Type Analysis:
By End User Analysis:
By Regional Analysis:
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Influenza Diagnostics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Influenza Diagnostics Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market
Cholesterol Screening/ Cholesterol Lab Testing Services Market
circulating tumor cell diagnostics market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Ranking Analysis
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Influenza Diagnostics: Market Overview
4.2 Geographic Analysis: Traditional Diagnostic Tests Market, By Type (2019)
4.3 Molecular Diagnostic Tests Market Size, By Type, 2019 vs 2025 (USD Million)
4.4 Life Cycle Analysis, By Region (2019)
5 Market Overview
5.1 Introduction
5.2 Drivers
5.2.1 Increasing Prevalence of Influenza
5.2.2 Growth in Research Funding for Influenza Diagnostics
5.2.3 Rising Demand for Faster Diagnosis and Control of Influenza
5.3 Restraints
5.3.1 Variability in Sensitivity and Specificity Among Influenza Diagnostic Tests
5.3.2 Stringent Regulatory Framework
5.3.3 Rising Healthcare Costs Limiting the Usage of Novel Influenza Diagnostic Techniques
5.4 Opportunities
5.4.1 Advancements in Genomic and Proteomic Technologies
5.4.2 Significant Growth Prospects in Developing Countries
5.5 Challenge
5.5.1 Dearth of Skilled Personnel to Handle Advanced Influenza Diagnostic Tools
5.6 Regulatory Framework
5.6.1 North America
5.6.2 Europe
5.6.3 Asia-Pacific
5.6.3.1 India
5.6.3.2 China
5.6.3.3 Australia
6 Influenza Diagnostics Market, By Test Type
6.1 Introduction
6.2 Traditional Diagnostic Tests
6.2.1 Rapid Influenza Detection Tests (RIDT)
6.2.2 Viral Culture
6.2.3 Direct Fluorescent Antibody (DFA) Tests
6.2.4 Serological Assays
6.3 Molecular Diagnostic Tests
6.3.1 RT-PCR
6.3.2 Nucleic Acid Sequence-Based Amplification (NASBA) Tests
6.3.3 Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
6.3.4 Simple Amplification-Based Assays (SAMBA)
6.3.5 Other Molecular Diagnostic Tests
7 Influenza Diagnostics Market, By End User
7.1 Introduction
7.2 Hospitals/Clinical Laboratories
7.3 Reference Laboratories
7.4 Other End Users
8 Influenza Diagnostics Market, By Region
8.1 Introduction
8.2 Pest Analysis
8.2.1 Political Factors
8.2.2 Economic Factors
8.2.3 Sociocultural Factors
8.2.4 Technological Factors
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 Rest of Europe
8.4 North America
8.4.1 U.S.
8.4.2 Canada
8.5 Asia-Pacific
8.6 Rest of the World (RoW)
9 Competitive Landscape
9.1 Overview
9.2 Leading Players in the Market
9.3 Competitive Situation and Trends
9.3.1 Product Launches and Approvals
9.3.2 Acquisitions
9.3.3 Expansions
9.3.4 Collaborations and Agreements
10 Company Profiles
10.1 Introduction
10.2 F. Hoffmann-La Roche AG
10.3 Becton, Dickinson and Company
10.4 Thermo Fisher Scientific Inc.
10.5 Alere Inc.
10.6 Diasorin S.P.A.
10.7 Quidel Corporation
10.8 Meridian Bioscience, Inc.
10.9 Analytik Jena AG (A Subsidiary of Endress+Hauser AG)
10.10 Luminex Corporation
10.11 SA Scientific, Ltd.
The Influenza Diagnostics Market has been segmented as below:
By Test Type Analysis:
By End User Analysis:
By Regional Analysis:
North America
Europe
Asia-Pacific
Rest of the World
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE